Clinical, laboratory findings and prognosis of 40 cases with progressive familial intrahepatic cholestasis;Progresif ailevi intrahepatik kolestazisli 40 vakanin klinik, laboratuvar bulgulari ve seyirleri

Cocuk Sagligi ve Hastaliklari Dergisi

Volumn 47, Issue 1, 2004, Pages 10-16

  Çoban, Bayram ^a   Gürakan, Figen ^a   Yüce, Aysel ^a   Özen, Hasan ^a   Temizel, Inci Nur Saltik ^a   Demir, Hülya ^a   Çaǧlar, Melda ^a   Koçak, Nurten ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Clinical course; Gamma glutamyl transferase; Progressive familial intrahepatic cholestasis

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE;

ARTICLE; BILE ACID BLOOD LEVEL; CHOLESTASIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONSANGUINEOUS MARRIAGE; DIAGNOSTIC ACCURACY; DISEASE COURSE; ENZYME BLOOD LEVEL; GROWTH RETARDATION; HUMAN; JAUNDICE; LABORATORY DIAGNOSIS; LIVER CIRRHOSIS; PORTAL HYPERTENSION; PRENATAL DIAGNOSIS; PRESCHOOL CHILD; PROGNOSIS; PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS; PRURITUS;

EID: 1542410128     PISSN: 00100161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Whitington PF. Chronic cholestasis of infancy. Pediatr Clin North Am 1996; 43: 1-26.
2. Arce DA, Costa H, Schwarz SM. Hepatobiliary disease in children. Clin Fam Pract 2000; 2: 189-212.
3. Koçak N, Aksoy A, Özsoylu Ş. Erken süt çocukluǧu döneminde kolestazisin klinik ve laboratuvar bulgularinin deǧerlendirilmesi. Çocuk Saǧliǧi ve Hastaliklari Dergisi 1988; 31: 243-252.
4. Balistreri WF. Pediatric Hepatology: a half century progress. Clin Liver Dis 2000; 4: 191-210.
5. Poupon R, Chazouilleres O, Poupon RE. Chronic cholestatic diseases. J Hepatol 2000; 32(suppl 1): 129-140.
6. Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Eng J Med 1998; 339: 1217-1227.
7. Emerick KM, Whitington PJ. Molecular basis of neonatal cholestasis. Pediatr Clin North Am 2002; 49: 221-235.
8. Phillips MJ, Suchy FJ. Mechanims and morphology of cholestasis. In: Suchy FJ, Sokol RJ, Balistreri WF (Eds). Liver Disease in Children (2nd ed), Philadelphia: Lippincott Williams & Wilkins, 2001: 23-37.
9. Kullack-Ublick GA, Stieger B, Hagenbuch B, Meier PJ. Hepatic transport of bile salts. Semin Liver Dis 2000; 20: 273-292.
10. Balistreri WF. Cholestasis. In: Behrman RE, Kliegman RM, Jenson HB (eds). Nelson Textbook of Pediatrics (16th ed). Philadelphia: WB Saunders, 2000: 1203-1207.
11. Fischler B, Papadogiannakis N, Nemeth A. Aetiological factors in neonatal cholestasis. Acta Paediatr 2001; 90: 88-92.
12. Stormon MO, Dorney SFA, Kameth KR, O'Loughlin EV, Gaskin KJ. The changing pattern of infantile cholestasis. J Pediatr Child Health 2001; 37: 47-50.
13. Coškun T. Safra asidi metabolizmasi bozukluklari. Özen G, Yüksel B (Eds) V. Ulusal Metabolik Hastaliklar ve Beslenme Kongresi Konferans Paneller ve Özet Kitabi, Adana, 1999: 139-163.
14. Ohura T, Kobayashi K, Abukawa D, et al. A novel inborn error of the metabolism detected by elevated methionine and/or galactose in newborn screening: neonatal intrahepatic cholestasis caused by citrin deficiency. Eur J Pediatr 2003; 162: 317-322.
15. Whitington PF, Emerick KM, Suchy FJ. Familial Hepatocellular Cholestasis. In: Suchy FJ, Sokol RJ, Balistreri WF (eds). Liver Disease in Children (2nd ed). Philadelphia: Lippincott Williams & Wilkins, 2001: 315-325.
16. Jacquemin E. Progressive familial intrahepatic cholestasis. J Gastroenterol Hepatol 1999; 14: 594-599.
17. Gürgey A, Özsoylu Ş, Koçak N. Fatal intrahepatic cholestasis. Turk J Pediatr 1976; 18: 53-57.
18. Colombo C, Okolicsanyi L, Strazzabosco M. Advances in familial and congenital cholestatic diseases. Clinical and diagnostic implications. Digest Liver Dis 2000; 32: 152-159.
19. van Mil SWC, Klomp LWJ, Bull LN, Houwen RHJ. FICI disease: a spectrum of intrahepatic cholestatic disorders. Semin Liver Dis 2001; 21: 535-544.
20. Thompson R, Straunieks S. BSEP. Function and role in progressive familial intrahepatic cholestasis. Semin Liver Dis 2001; 21: 545-550.
21. Jacquemin E. Role of multidrug resistance 3 deficiency in pediatric and adult liver disease:one gene for three diseases. Semin Liver Dis 2001; 21: 551-562.
22. Jansen PL, Müller M. The molecular genetics of familial intrahepatic cholestasis. Gut 2000; 47: 1-5.
23. Whitington PF, Freese DK, Alonso EM, Schwarzenberg SJ, Sharp HL. Clinical and biochemical findings in progressive familial intrahepatic cholestasis. J Pediatr Gastoenterol Nutr 1994; 18: 134-141.
24. Ismail H, Kalicinski P, Markiewicz M, et al. Treatment of progressive familial intrahepatic cholestasis: Liver transplantation or partial external biliary diversion. Pediatr Transplant 1999; 3: 219-224.
25. Knisely AS. Progressive familial intrahepatic cholestasis: a personal perspective. Pediatr and Develop Pathol 2000; 3: 113-125.
26. Prall TR, LaRusso NF. Biliary tract physiology. Curr Opin Gastroenterol 2000; 16: 432-436.
27. Tietz P, LaRusso NF. Cholangiocyte physiology. Curr Opin Gastroenterol 2002; 18: 360-365.
28. Jansen PLM. Foreword: from classic bile physiology to cloned transporters. Semin Liver Dis 2000; 20: 245-250.
29. Kullack-Ublick GA, Stieger B, Hagenbuch B, Meier PJ. Hepatic transport of bile salts. Semin Liver Dis 2000; 20: 273-292.
30. Jacquemin E, Setchell KD, O'Connell NC, et al. A new cause of progressive intrahepatic cholestasis: 3 beta-hydroxy-C27-steroid dehydrogenase/isomerase deficiency. J Pediatr 1994; 125: 379-384.
31. Setchell KD, Suchy FJ, Welsh MB, Zimmer-Nechemias L, Hesbi J, Balistreri WF. Delta 4-3-oxosteroid 5 beta-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis. J Clin Invest 1988; 82: 2148-2157.
32. Shneider BJ. Genetic cholestatic syndromes. J Pediatr Gastroenterol Nutr 1999; 28: 124-131.
33. Jacquemin E, de Vree JM, Cresteil D, et al. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 2001; 120: 1448-1458.
34. Chen HL, Chong PS, Hsu HC, et al. FICI and BSEP defects in Taiwanese patients with chronic intrahepatic cholestasis with low γ -glutamyltranspeptidase levels. J Pediatr 2002; 140: 119-124.
35. Chen HL, Chang PS, Hsu HC, et al. Progressive familial intrahepatic cholestasis with high gammaglutamyltranspeptidase levels in the Taiwanese infants: role of MDR3 gene defect? Pediatr Res 2001; 50: 50-55.
36. Deleuze JF, Jacquemin E, Dubuisson C, et al. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology 1996; 23: 904-908.
37. Alonso EM, Snover DC, Montag A, Freese DK, Whitington PF. Histologic pathology of the liver in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 1994; 18: 128-134.
38. Braegger CP, Altorfer J. Endoscopic biliary sphincterotomy and stone extraction in a child with cholelithiasis complicating Byler's disease. J Pediatr Gastroenterol Nutr 1996; 23: 614-617.
39. Lazaridis KN, Gores GJ, Lindor KD. Ursodeoxycholic acid 'mechanisms of action and clinical use rn hepatobiliary disorders'. J Hepatol 2001; 35: 134-146.
40. Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 2002; 36: 525-531.
41. Kumar D, Tandon RK. Use of ursodeoxycholic acid in liver diseases. J Gastroenterol Hepatol 2001; 16: 3-14.
42. Jacquemin E, Hermans D, Myara A, et al. Ursodeoxycholic acid therapy in pediatric patients with progressive intrahepatic cholestasis. Hepatology 1997; 25: 519-523.
43. Dinler G, Koçak N, Özen H, Yüce A, Gürakan F. Ursodeoxycholic acid treatment in children with Byler disease. Pediatr Int 1999; 41: 662-665.
44. Rebhandl W, Felberbauer FX, Turnbull J, et al. Biliary diversion by use of the appendix (cholecystoappendicostomy) in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 1999; 28: 217-219.
45. Whitington PF, Whitington GL. Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis. Gastroenterology 1988; 95: 130-136.
46. Kondo S, Hashimato T, Suzuki T, et al. Living related liver transplantation in two Byler disease families. Transplantation Proceedings 2000; 32: 2185-2186.
47. Ujhazy P, Ortiz D, Misra S, et al. Familial intrahepatic cholestasis 1: Studies of localization and function. Hepatology 2001; 34: 768-775.
48. Bull LN, Jujin JA, Liao M, et al. Fine resolution mapping by haplotype evaluation: the examples of PFICI and BRIC. Hum Genet 1999; 104: 241-248.
49. Ortiz D, Arias IM. MDR3 mutations: a glimpse into pandora's box and the future of canalicular pathophysiology. Gastroenterology 2001; 120: 1549-1552.